# Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib

> **NCT07264985** · — · NOT_YET_RECRUITING · sponsor: **Hubei Cancer Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Breast Cancer
- Drug-Related Side Effects
- Diarrhea

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07264985
- **Lead sponsor:** Hubei Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2026-06
- **Final completion:** 2026-07
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07264985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07264985, "Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07264985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*